Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 31, 2013
[Status quo of children's preventative medicine programmes--results of the first German nationwide workshop 2011 in Frankfurt am Main]S Hock, Y Berchner, O Blankenstein, et al.
International Journal of Nursing Studies|February 1, 2026
Strategies to support safe wandering in care homes for older adults - what works, for whom, and in which circumstances?: A realist synthesisEmma S Hock, Bryony Waters-Harvey, Alys Wyn Griffiths, et al.
The Journal of Rheumatology|February 17, 2017
The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate MethotrexateMatt D Stevenson, Allan J Wailoo, Jonathan C Tosh, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2020
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depressionMaurizio Fava, Erica Mazzone, Marlene Freeman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2021
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind studyAnna Feeney, Rebecca S Hock, Marlene P Freeman, et al.
Journal of Affective Disorders|September 9, 2019
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Rebecca S Hock, et al.
Depression and Anxiety|January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Marlene P Freeman, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2014
Discovery of highly selective alkyne semihydrogenation catalysts based on first-row transition-metallated porous organic polymersKristine K Tanabe, Magali S Ferrandon, Nathan A Siladke, et al.
Dalton Transactions (Cambridge, England : 2003)|July 18, 2018
Nuclearity effects in supported, single-site Fe(ii) hydrogenation pre-catalystsRyan R Langeslay, Hyuntae Sohn, Bo Hu, et al.
Plos Medicine|January 25, 2012
A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has comeJudith K Bass, Thomas H Bornemann, Matthew Burkey, et al.
Pageof 11